Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a

NCT01414231 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

850

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukaemia

Interventions

DRUG: Cytarabine

Sponsor

University of Leipzig